200230 — Telcon RF Pharmaceutical Balance Sheet

0.000.00%

Last trade - 00:00

TechnologyHighly SpeculativeMicro CapValue Trap

Annual balance sheet for Telcon RF Pharmaceutical, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	ARS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	23,195	11,963	10,519	10,037	32,125
Net Total Accounts Receivable
Net Total Receivables	9,747	6,455	16,284	9,321	17,097
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	37,357	23,127	32,989	26,011	57,735
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	9,320	8,038	8,468	11,180	9,877
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	168,030	119,255	140,415	153,588	156,668
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	60,113	34,329	34,924	69,720	46,259
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	61,450	35,132	35,956	70,759	48,167
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	106,580	84,123	104,459	82,830	108,501
Total Liabilities & Shareholders' Equity	168,030	119,255	140,415	153,588	156,668
Total Common Shares Outstanding